Beebe D P
Thromb Res. 1987 Apr 15;46(2):241-54. doi: 10.1016/0049-3848(87)90286-6.
Binding of purified recombinant human tissue plasminogen activator to cultures of human umbilical vein endothelial cells (HUVEC) was studied in vitro. 125I-tPA was shown to bind to HUVEC in a specific, saturable, and dissociable manner. Scatchard analysis revealed a low affinity binding site with Keq = 4.2 X 10(6) M-1 and 1.2 X 10(7) sites per cell. Binding of tPA was inhibited by L-lysine, e-aminocaproic acid, and D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone but not by carbohydrates including mannose, galactose, N-acetyl glucosamine and N-acetyl galactosamine. Neat human plasma abrogates but does not totally inhibit binding of tPA to HUVEC. These results may indicate a role for endothelial cells in the removal of tPA from the circulation in vivo.
在体外研究了纯化的重组人组织型纤溶酶原激活剂与人脐静脉内皮细胞(HUVEC)培养物的结合情况。结果表明,¹²⁵I-tPA以特异性、可饱和且可解离的方式与HUVEC结合。Scatchard分析显示存在一个低亲和力结合位点,其平衡常数Keq = 4.2×10⁶ M⁻¹,每个细胞有1.2×10⁷个位点。tPA的结合受到L-赖氨酸、ε-氨基己酸和D-苯丙氨酰-L-脯氨酰-L-精氨酸氯甲基酮的抑制,但不受包括甘露糖、半乳糖、N-乙酰葡糖胺和N-乙酰半乳糖胺在内的碳水化合物的抑制。纯人血浆可消除但不能完全抑制tPA与HUVEC的结合。这些结果可能表明内皮细胞在体内从循环中清除tPA方面发挥作用。